Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Miguel Fernandes

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Acta Reumatologica Portuguesa|November 3, 2020
Belimumab in the treatment of Portuguese Systemic Lupus Erythematosus patients: a real-life multicenter studyBruno Miguel Fernandes, Sofia Barreira, João Eurico Fonseca, et al.
ARP Rheumatology|May 13, 2023
The impact of antinuclear antibodies seroconversion induced by anti-tumor necrosis factor α agents on the clinical outcomes in rheumatic patientsAna Martins, Daniela Oliveira, Frederico Rajão Martins, et al.
Drugs & Aging|November 18, 2020
Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort StudyRaquel Freitas, Fátima Godinho, Nathalie Madeira, et al.
ARP Rheumatology|July 8, 2023
Effectiveness of biosimilar infliximab CT-P13 compared to originator infliximab in biological-naïve patients with rheumatoid arthritis and axial spondyloarthritis: data from the Portuguese RegisterJosé Marona, Alexandre Sepriano, Sofia Ramiro, et al.
ARP Rheumatology|May 28, 2022
Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registryRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Acta Reumatologica Portuguesa|January 9, 2021
Remission and low disease activity matrix tools: results in real-world rheumatoid arthritis patients under anti-TNF therapySara Ganhão, Raquel Lucas, João Eurico Fonseca, et al.
Clinical Rheumatology|November 20, 2021
Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohortRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Frontiers in Medicine|June 30, 2022
Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal-A Multicenter, Nationwide StudyAna Rita Cruz-Machado, Sofia C Barreira, Matilde Bandeira, et al.
ARP Rheumatology|May 28, 2022
Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 updateBruno Miguel Fernandes, Francisca Guimarães, Diogo Esperança Almeida, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Acta Reumatologica Portuguesa|November 3, 2020
Belimumab in the treatment of Portuguese Systemic Lupus Erythematosus patients: a real-life multicenter studyBruno Miguel Fernandes, Sofia Barreira, João Eurico Fonseca, et al.
ARP Rheumatology|May 13, 2023
The impact of antinuclear antibodies seroconversion induced by anti-tumor necrosis factor α agents on the clinical outcomes in rheumatic patientsAna Martins, Daniela Oliveira, Frederico Rajão Martins, et al.
Drugs & Aging|November 18, 2020
Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort StudyRaquel Freitas, Fátima Godinho, Nathalie Madeira, et al.
ARP Rheumatology|July 8, 2023
Effectiveness of biosimilar infliximab CT-P13 compared to originator infliximab in biological-naïve patients with rheumatoid arthritis and axial spondyloarthritis: data from the Portuguese RegisterJosé Marona, Alexandre Sepriano, Sofia Ramiro, et al.
ARP Rheumatology|May 28, 2022
Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registryRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Acta Reumatologica Portuguesa|January 9, 2021
Remission and low disease activity matrix tools: results in real-world rheumatoid arthritis patients under anti-TNF therapySara Ganhão, Raquel Lucas, João Eurico Fonseca, et al.
Clinical Rheumatology|November 20, 2021
Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohortRaquel Freitas, Patrícia Martins, Eduardo Dourado, et al.
Frontiers in Medicine|June 30, 2022
Risk Factors for Infection, Predictors of Severe Disease, and Antibody Response to COVID-19 in Patients With Inflammatory Rheumatic Diseases in Portugal-A Multicenter, Nationwide StudyAna Rita Cruz-Machado, Sofia C Barreira, Matilde Bandeira, et al.
ARP Rheumatology|May 28, 2022
Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 updateBruno Miguel Fernandes, Francisca Guimarães, Diogo Esperança Almeida, et al.
Pageof 2